Kelsey Starks, MS CCC-SLP - Speech-Language Pathologist in Ashdown, AR

Kelsey Starks, MS CCC-SLP is a Speech-language Pathologist based in Ashdown, Arkansas. Kelsey Starks is licensed to practice in Arkansas (license number 202314) and her current practice location is 974 Lr 17, Ashdown, Arkansas. She can be reached at her office (for appointments etc.) via phone at (903) 277-4451.

NPI number for Kelsey Starks is 1144691031 and her current mailing address is 974 Lr 17, Ashdown, Arkansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1144691031.

Contact Information

Kelsey Starks, MS CCC-SLP
974 Lr 17,
Ashdown, AR 71822-9456
(903) 277-4451
Not Available



Healthcare Provider's Profile

Full NameKelsey Starks
GenderFemale
SpecialitySpeech-language Pathologist
Location974 Lr 17, Ashdown, Arkansas
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1144691031
  • Provider Enumeration Date: 10/17/2015
  • Last Update Date: 08/10/2023

Medical Identifiers

Medical identifiers for Kelsey Starks such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1144691031NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 120205 (Texas)Secondary
235Z00000XSpeech-language Pathologist 202314 (Arkansas)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kelsey Starks is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Kelsey Starks, MS CCC-SLP
974 Lr 17,
Ashdown, AR 71822-9456

Ph: (903) 277-4451
Kelsey Starks, MS CCC-SLP
974 Lr 17,
Ashdown, AR 71822-9456

Ph: (903) 277-4451

News Archive

AutoGenomics introduces first automated molecular assay for Familial Mediterranean Fever

AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever (FMF). The INFINITIĀ® Familial Mediterranean Fever Panel provides simultaneous multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin on the automated INFINITIĀ® Analyzer. FMF is prominently present in the Armenian people, Sephardi Jews, Greeks, Arabs and Turks.

Symmetry Medical to increase operational efficiency and drive annualized cost savings by restructuring

Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today a restructuring that includes a facility consolidation and other staff reductions designed to increase operational efficiency and drive annualized cost savings.

American features series on HIV/AIDS: Prevention Strategies, MSM, Idus

A Scientific American series examines how recent scientific advances will guide future efforts to thwart HIV/AIDS and also looks at the epidemic among men who have sex with men (MSM) and injecting drug users (IDUs).

Beryl Institute awards $1,000 grants to health care organizations

As part of its commitment to supporting efforts to improve the patient experience in healthcare, The Beryl Institute has awarded $1,000 grants to ten health care organizations that are exploring effective methods for addressing patient experience issues.

Novel proteomics based method detects inhibition of intracellular deubiquitylating enzymes

Researchers at the University of Oxford and Progenra, Inc. are pleased to announce the publication of a research article entitled "Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes" that details a novel proteomics based method to detect inhibition of intracellular deubiquitylating enzymes (DUBs).

Read more News

› Verified 4 days ago


Speech-Language Pathologist in Ashdown, AR

Mrs. Ashley Renee Sanders, MS CCC/SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 460 Nw Front St, Ashdown, AR 71822
Phone: 870-898-4404    
Anna Ward Ramage, M.A. CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 511 N 2nd St, Ashdown, AR 71822
Phone: 870-898-3208    
Taylor Elyse Ledford,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 751 Rankin St, Ashdown, AR 71822
Phone: 870-898-3208    
Donna K Kneipp-lingle, MA, CCC, SLP
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 460 Nw Front St, Ashdown, AR 71822
Phone: 870-898-4404    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.